nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—WEE2—endocrine gland—appendix cancer	0.0217	0.0217	CbGeAlD
Dasatinib—BMX—epithelium—appendix cancer	0.0172	0.0172	CbGeAlD
Dasatinib—TEC—endocrine gland—appendix cancer	0.0164	0.0164	CbGeAlD
Dasatinib—STAT5B—epithelium—appendix cancer	0.0153	0.0153	CbGeAlD
Dasatinib—EPHB1—female gonad—appendix cancer	0.0139	0.0139	CbGeAlD
Dasatinib—BMPR1B—epithelium—appendix cancer	0.0122	0.0122	CbGeAlD
Dasatinib—SIK2—endocrine gland—appendix cancer	0.0114	0.0114	CbGeAlD
Dasatinib—TEC—lymph node—appendix cancer	0.0114	0.0114	CbGeAlD
Dasatinib—PKMYT1—endocrine gland—appendix cancer	0.0111	0.0111	CbGeAlD
Dasatinib—FRK—endocrine gland—appendix cancer	0.0111	0.0111	CbGeAlD
Dasatinib—PTK6—female gonad—appendix cancer	0.0109	0.0109	CbGeAlD
Dasatinib—BMX—endocrine gland—appendix cancer	0.0108	0.0108	CbGeAlD
Dasatinib—STAT5B—female gonad—appendix cancer	0.0103	0.0103	CbGeAlD
Dasatinib—TXK—endocrine gland—appendix cancer	0.0103	0.0103	CbGeAlD
Dasatinib—PTK6—endocrine gland—appendix cancer	0.0102	0.0102	CbGeAlD
Dasatinib—CSK—smooth muscle tissue—appendix cancer	0.00997	0.00997	CbGeAlD
Dasatinib—STAT5B—endocrine gland—appendix cancer	0.0096	0.0096	CbGeAlD
Dasatinib—RIPK2—epithelium—appendix cancer	0.0096	0.0096	CbGeAlD
Dasatinib—SIK3—female gonad—appendix cancer	0.00929	0.00929	CbGeAlD
Dasatinib—ERBB3—epithelium—appendix cancer	0.00919	0.00919	CbGeAlD
Dasatinib—EPHB1—lymph node—appendix cancer	0.00892	0.00892	CbGeAlD
Dasatinib—SIK3—endocrine gland—appendix cancer	0.00864	0.00864	CbGeAlD
Dasatinib—ZAK—female gonad—appendix cancer	0.00863	0.00863	CbGeAlD
Dasatinib—MAPK14—epithelium—appendix cancer	0.00856	0.00856	CbGeAlD
Dasatinib—BMPR1B—female gonad—appendix cancer	0.00828	0.00828	CbGeAlD
Dasatinib—MAPK14—smooth muscle tissue—appendix cancer	0.00824	0.00824	CbGeAlD
Dasatinib—BTK—female gonad—appendix cancer	0.00824	0.00824	CbGeAlD
Dasatinib—TNK2—female gonad—appendix cancer	0.00812	0.00812	CbGeAlD
Dasatinib—EPHB4—epithelium—appendix cancer	0.00811	0.00811	CbGeAlD
Dasatinib—JAK2—epithelium—appendix cancer	0.00805	0.00805	CbGeAlD
Dasatinib—ZAK—endocrine gland—appendix cancer	0.00803	0.00803	CbGeAlD
Dasatinib—EPHA2—epithelium—appendix cancer	0.00796	0.00796	CbGeAlD
Dasatinib—EPHA5—endocrine gland—appendix cancer	0.00786	0.00786	CbGeAlD
Dasatinib—LYN—endocrine gland—appendix cancer	0.00782	0.00782	CbGeAlD
Dasatinib—EPHB4—smooth muscle tissue—appendix cancer	0.00782	0.00782	CbGeAlD
Dasatinib—JAK2—smooth muscle tissue—appendix cancer	0.00776	0.00776	CbGeAlD
Dasatinib—BMPR1B—endocrine gland—appendix cancer	0.0077	0.0077	CbGeAlD
Dasatinib—FYN—smooth muscle tissue—appendix cancer	0.00765	0.00765	CbGeAlD
Dasatinib—TESK1—female gonad—appendix cancer	0.00763	0.00763	CbGeAlD
Dasatinib—TNK2—endocrine gland—appendix cancer	0.00755	0.00755	CbGeAlD
Dasatinib—STK36—female gonad—appendix cancer	0.00751	0.00751	CbGeAlD
Dasatinib—EPHB3—female gonad—appendix cancer	0.00751	0.00751	CbGeAlD
Dasatinib—BMX—lymph node—appendix cancer	0.00749	0.00749	CbGeAlD
Dasatinib—MAP4K5—smooth muscle tissue—appendix cancer	0.00748	0.00748	CbGeAlD
Dasatinib—BLK—lymph node—appendix cancer	0.00741	0.00741	CbGeAlD
Dasatinib—LIMK2—female gonad—appendix cancer	0.00726	0.00726	CbGeAlD
Dasatinib—TESK1—endocrine gland—appendix cancer	0.0071	0.0071	CbGeAlD
Dasatinib—TXK—lymph node—appendix cancer	0.00709	0.00709	CbGeAlD
Dasatinib—STK35—female gonad—appendix cancer	0.00704	0.00704	CbGeAlD
Dasatinib—CSK—female gonad—appendix cancer	0.00699	0.00699	CbGeAlD
Dasatinib—STK36—endocrine gland—appendix cancer	0.00698	0.00698	CbGeAlD
Dasatinib—YES1—smooth muscle tissue—appendix cancer	0.00691	0.00691	CbGeAlD
Dasatinib—HCK—female gonad—appendix cancer	0.0069	0.0069	CbGeAlD
Dasatinib—SRC—epithelium—appendix cancer	0.0069	0.0069	CbGeAlD
Dasatinib—ABL2—female gonad—appendix cancer	0.00686	0.00686	CbGeAlD
Dasatinib—PDGFRA—smooth muscle tissue—appendix cancer	0.00678	0.00678	CbGeAlD
Dasatinib—LIMK2—endocrine gland—appendix cancer	0.00675	0.00675	CbGeAlD
Dasatinib—SRC—smooth muscle tissue—appendix cancer	0.00665	0.00665	CbGeAlD
Dasatinib—STAT5B—lymph node—appendix cancer	0.00664	0.00664	CbGeAlD
Dasatinib—STK35—endocrine gland—appendix cancer	0.00654	0.00654	CbGeAlD
Dasatinib—CSK—endocrine gland—appendix cancer	0.0065	0.0065	CbGeAlD
Dasatinib—RIPK2—female gonad—appendix cancer	0.00649	0.00649	CbGeAlD
Dasatinib—HCK—endocrine gland—appendix cancer	0.00642	0.00642	CbGeAlD
Dasatinib—SIK1—female gonad—appendix cancer	0.00634	0.00634	CbGeAlD
Dasatinib—EPHA4—female gonad—appendix cancer	0.00627	0.00627	CbGeAlD
Dasatinib—ERBB3—female gonad—appendix cancer	0.00621	0.00621	CbGeAlD
Dasatinib—MAP3K2—female gonad—appendix cancer	0.00615	0.00615	CbGeAlD
Dasatinib—EPHA3—lymph node—appendix cancer	0.00614	0.00614	CbGeAlD
Dasatinib—RIPK2—endocrine gland—appendix cancer	0.00603	0.00603	CbGeAlD
Dasatinib—SIK3—lymph node—appendix cancer	0.00597	0.00597	CbGeAlD
Dasatinib—CSF1R—smooth muscle tissue—appendix cancer	0.00597	0.00597	CbGeAlD
Dasatinib—SIK1—endocrine gland—appendix cancer	0.00589	0.00589	CbGeAlD
Dasatinib—EPHA4—endocrine gland—appendix cancer	0.00583	0.00583	CbGeAlD
Dasatinib—MAPK14—female gonad—appendix cancer	0.00578	0.00578	CbGeAlD
Dasatinib—ERBB3—endocrine gland—appendix cancer	0.00578	0.00578	CbGeAlD
Dasatinib—FGR—female gonad—appendix cancer	0.00576	0.00576	CbGeAlD
Dasatinib—LCK—female gonad—appendix cancer	0.00576	0.00576	CbGeAlD
Dasatinib—MAP3K2—endocrine gland—appendix cancer	0.00572	0.00572	CbGeAlD
Dasatinib—KIT—epithelium—appendix cancer	0.00562	0.00562	CbGeAlD
Dasatinib—ZAK—lymph node—appendix cancer	0.00555	0.00555	CbGeAlD
Dasatinib—PDGFRB—epithelium—appendix cancer	0.00549	0.00549	CbGeAlD
Dasatinib—EPHB4—female gonad—appendix cancer	0.00548	0.00548	CbGeAlD
Dasatinib—JAK2—female gonad—appendix cancer	0.00544	0.00544	CbGeAlD
Dasatinib—KIT—smooth muscle tissue—appendix cancer	0.00542	0.00542	CbGeAlD
Dasatinib—MAPK14—endocrine gland—appendix cancer	0.00538	0.00538	CbGeAlD
Dasatinib—EPHA2—female gonad—appendix cancer	0.00538	0.00538	CbGeAlD
Dasatinib—FYN—female gonad—appendix cancer	0.00537	0.00537	CbGeAlD
Dasatinib—FGR—endocrine gland—appendix cancer	0.00536	0.00536	CbGeAlD
Dasatinib—BMPR1B—lymph node—appendix cancer	0.00532	0.00532	CbGeAlD
Dasatinib—BTK—lymph node—appendix cancer	0.00529	0.00529	CbGeAlD
Dasatinib—PDGFRB—smooth muscle tissue—appendix cancer	0.00529	0.00529	CbGeAlD
Dasatinib—MAP4K5—female gonad—appendix cancer	0.00525	0.00525	CbGeAlD
Dasatinib—MAP3K3—female gonad—appendix cancer	0.00525	0.00525	CbGeAlD
Dasatinib—TNK2—lymph node—appendix cancer	0.00522	0.00522	CbGeAlD
Dasatinib—FMO3—endocrine gland—appendix cancer	0.00517	0.00517	CbGeAlD
Dasatinib—EPHB4—endocrine gland—appendix cancer	0.0051	0.0051	CbGeAlD
Dasatinib—JAK2—endocrine gland—appendix cancer	0.00506	0.00506	CbGeAlD
Dasatinib—EPHB6—female gonad—appendix cancer	0.00501	0.00501	CbGeAlD
Dasatinib—EPHA2—endocrine gland—appendix cancer	0.005	0.005	CbGeAlD
Dasatinib—FYN—endocrine gland—appendix cancer	0.00499	0.00499	CbGeAlD
Dasatinib—TESK1—lymph node—appendix cancer	0.00491	0.00491	CbGeAlD
Dasatinib—MAP4K5—endocrine gland—appendix cancer	0.00488	0.00488	CbGeAlD
Dasatinib—MAP3K3—endocrine gland—appendix cancer	0.00488	0.00488	CbGeAlD
Dasatinib—YES1—female gonad—appendix cancer	0.00485	0.00485	CbGeAlD
Dasatinib—STK36—lymph node—appendix cancer	0.00483	0.00483	CbGeAlD
Dasatinib—EPHB3—lymph node—appendix cancer	0.00483	0.00483	CbGeAlD
Dasatinib—PDGFRA—female gonad—appendix cancer	0.00475	0.00475	CbGeAlD
Dasatinib—ABL1—smooth muscle tissue—appendix cancer	0.00472	0.00472	CbGeAlD
Dasatinib—LIMK2—lymph node—appendix cancer	0.00467	0.00467	CbGeAlD
Dasatinib—SRC—female gonad—appendix cancer	0.00466	0.00466	CbGeAlD
Dasatinib—STK35—lymph node—appendix cancer	0.00452	0.00452	CbGeAlD
Dasatinib—YES1—endocrine gland—appendix cancer	0.00451	0.00451	CbGeAlD
Dasatinib—CSK—lymph node—appendix cancer	0.00449	0.00449	CbGeAlD
Dasatinib—HCK—lymph node—appendix cancer	0.00444	0.00444	CbGeAlD
Dasatinib—PDGFRA—endocrine gland—appendix cancer	0.00442	0.00442	CbGeAlD
Dasatinib—ABL2—lymph node—appendix cancer	0.00441	0.00441	CbGeAlD
Dasatinib—SRC—endocrine gland—appendix cancer	0.00434	0.00434	CbGeAlD
Dasatinib—MAP2K5—female gonad—appendix cancer	0.00429	0.00429	CbGeAlD
Dasatinib—CSF1R—female gonad—appendix cancer	0.00419	0.00419	CbGeAlD
Dasatinib—RIPK2—lymph node—appendix cancer	0.00417	0.00417	CbGeAlD
Dasatinib—SIK1—lymph node—appendix cancer	0.00407	0.00407	CbGeAlD
Dasatinib—EPHA4—lymph node—appendix cancer	0.00403	0.00403	CbGeAlD
Dasatinib—CYP1B1—smooth muscle tissue—appendix cancer	0.00399	0.00399	CbGeAlD
Dasatinib—ERBB3—lymph node—appendix cancer	0.00399	0.00399	CbGeAlD
Dasatinib—MAP2K5—endocrine gland—appendix cancer	0.00399	0.00399	CbGeAlD
Dasatinib—MAP3K2—lymph node—appendix cancer	0.00395	0.00395	CbGeAlD
Dasatinib—CSF1R—endocrine gland—appendix cancer	0.00389	0.00389	CbGeAlD
Dasatinib—KIT—female gonad—appendix cancer	0.0038	0.0038	CbGeAlD
Dasatinib—MAPK14—lymph node—appendix cancer	0.00372	0.00372	CbGeAlD
Dasatinib—PDGFRB—female gonad—appendix cancer	0.00371	0.00371	CbGeAlD
Dasatinib—FGR—lymph node—appendix cancer	0.0037	0.0037	CbGeAlD
Dasatinib—LCK—lymph node—appendix cancer	0.0037	0.0037	CbGeAlD
Dasatinib—FMO3—lymph node—appendix cancer	0.00358	0.00358	CbGeAlD
Dasatinib—KIT—endocrine gland—appendix cancer	0.00353	0.00353	CbGeAlD
Dasatinib—EPHB4—lymph node—appendix cancer	0.00352	0.00352	CbGeAlD
Dasatinib—JAK2—lymph node—appendix cancer	0.0035	0.0035	CbGeAlD
Dasatinib—EPHA2—lymph node—appendix cancer	0.00346	0.00346	CbGeAlD
Dasatinib—PDGFRB—endocrine gland—appendix cancer	0.00345	0.00345	CbGeAlD
Dasatinib—FYN—lymph node—appendix cancer	0.00345	0.00345	CbGeAlD
Dasatinib—MAP4K5—lymph node—appendix cancer	0.00337	0.00337	CbGeAlD
Dasatinib—MAP3K3—lymph node—appendix cancer	0.00337	0.00337	CbGeAlD
Dasatinib—ABL1—female gonad—appendix cancer	0.00331	0.00331	CbGeAlD
Dasatinib—EPHB6—lymph node—appendix cancer	0.00322	0.00322	CbGeAlD
Dasatinib—YES1—lymph node—appendix cancer	0.00312	0.00312	CbGeAlD
Dasatinib—ABL1—endocrine gland—appendix cancer	0.00308	0.00308	CbGeAlD
Dasatinib—PDGFRA—lymph node—appendix cancer	0.00306	0.00306	CbGeAlD
Dasatinib—SRC—lymph node—appendix cancer	0.003	0.003	CbGeAlD
Dasatinib—CYP1A1—epithelium—appendix cancer	0.00293	0.00293	CbGeAlD
Dasatinib—CYP1B1—female gonad—appendix cancer	0.0028	0.0028	CbGeAlD
Dasatinib—MAP2K5—lymph node—appendix cancer	0.00276	0.00276	CbGeAlD
Dasatinib—CSF1R—lymph node—appendix cancer	0.00269	0.00269	CbGeAlD
Dasatinib—CYP1B1—endocrine gland—appendix cancer	0.00261	0.00261	CbGeAlD
Dasatinib—KIT—lymph node—appendix cancer	0.00244	0.00244	CbGeAlD
Dasatinib—PDGFRB—lymph node—appendix cancer	0.00239	0.00239	CbGeAlD
Dasatinib—ABL1—lymph node—appendix cancer	0.00213	0.00213	CbGeAlD
Dasatinib—ABCG2—female gonad—appendix cancer	0.00209	0.00209	CbGeAlD
Dasatinib—CYP1A1—female gonad—appendix cancer	0.00198	0.00198	CbGeAlD
Dasatinib—CYP3A5—female gonad—appendix cancer	0.00194	0.00194	CbGeAlD
Dasatinib—CYP1A2—endocrine gland—appendix cancer	0.00187	0.00187	CbGeAlD
Dasatinib—CYP1A1—endocrine gland—appendix cancer	0.00184	0.00184	CbGeAlD
Dasatinib—CYP1B1—lymph node—appendix cancer	0.0018	0.0018	CbGeAlD
Dasatinib—CYP3A5—endocrine gland—appendix cancer	0.0018	0.0018	CbGeAlD
Dasatinib—ABCB1—epithelium—appendix cancer	0.00152	0.00152	CbGeAlD
Dasatinib—CYP3A4—endocrine gland—appendix cancer	0.00135	0.00135	CbGeAlD
Dasatinib—ABCG2—lymph node—appendix cancer	0.00134	0.00134	CbGeAlD
Dasatinib—CYP1A1—lymph node—appendix cancer	0.00127	0.00127	CbGeAlD
Dasatinib—ABCB1—female gonad—appendix cancer	0.00103	0.00103	CbGeAlD
Dasatinib—ABCB1—endocrine gland—appendix cancer	0.000957	0.000957	CbGeAlD
Dasatinib—ABCB1—lymph node—appendix cancer	0.000661	0.000661	CbGeAlD
